Revvity (RVTY) Share-based Compensation (2009 - 2026)
Revvity's (RVTY) quarterly Share-based Compensation came in at $10.7 million in Q3 2026, up 5.9% on a YoY basis from $10.1 million in Q3 2025, and up 23.13% quarter-over-quarter from $8.7 million in Q2 2026.
Analysis
Revvity (RVTY) Share-based Compensation (2009 - 2026) Analysis & Trends
Revvity (RVTY) has reported Share-based Compensation for 18 consecutive years, with $10.7 million the latest figure, recorded in Q3 2026.
- For the quarter ending Q3 2026, Share-based Compensation rose 5.9% year-over-year to $10.7 million; the trailing twelve-month figure through Jul 2026 stood at $24.4 million (down 26.98% YoY), and the FY2025 full-year result was $22.8 million, down 39.57% from the prior year.
- Share-based Compensation rose to $10.7 million in Q3 2026 per RVTY's latest filing, from $8.7 million in the prior quarter.
- Across five years, Share-based Compensation topped out at $34.8 million in Q1 2023 and bottomed at -$4.1 million in Q4 2025.
- Historically, Share-based Compensation has averaged $10.7 million across 5 years, with a median of $10.3 million in 2024.
- The sharpest annual moves came in 2022 and 2025: Share-based Compensation jumped 179.97% in 2022, then slumped 180.57% in 2025.
- Over 5 years, Share-based Compensation stood at $14.4 million in 2022, then plunged by 50.26% to $7.2 million in 2023, then decreased by 29.63% to $5.1 million in 2024, then plunged by 180.57% to -$4.1 million in 2025, then surged by 363.6% to $10.7 million in 2026.
- According to Business Quant data, Share-based Compensation over the past three periods registered $10.7 million, $8.7 million, and -$4.1 million for Q3 2026, Q2 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 241.68 Bn | 237.61 Bn | 8.34 Bn | 82.00 Mn |
| 2 | Danaher | 147.34 Bn | 142.99 Bn | 3.61 Bn | 93.00 Mn |
| 3 | Agilent Technologies | 43.34 Bn | 41.59 Bn | 1.04 Bn | 2.00 Mn |
| 4 | Illumina | 34.58 Bn | 33.41 Bn | 770.00 Mn | 73.00 Mn |
| 5 | Revvity | 16.31 Bn | 15.29 Bn | 416.87 Mn | 10.73 Mn |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn | 5.23 Mn |
| 7 | Bio-Rad Laboratories | 10.16 Bn | 8.54 Bn | 345.80 Mn | - |
| 8 | Repligen | 9.77 Bn | 8.75 Bn | 110.04 Mn | 76.90 Mn |
| 9 | 10x Genomics | 9.45 Bn | 8.90 Bn | 112.50 Mn | 25.62 Mn |
| 10 | Bruker | 9.26 Bn | 9.04 Bn | 416.00 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 5, 2026 | 10.73 Mn |
| Apr 5, 2026 | 8.72 Mn |
| Dec 28, 2025 | -4.07 Mn |
| Sep 28, 2025 | 9.05 Mn |
| Jun 29, 2025 | 10.13 Mn |
| Mar 30, 2025 | 7.73 Mn |
| Dec 29, 2024 | 5.05 Mn |
| Sep 29, 2024 | 10.54 Mn |
| Jun 30, 2024 | 10.53 Mn |
| Mar 31, 2024 | 11.69 Mn |
| Dec 31, 2023 | 7.18 Mn |
| Oct 1, 2023 | 10.70 Mn |
| Jul 2, 2023 | 13.63 Mn |
| Apr 2, 2023 | 9.89 Mn |
| Jan 1, 2023 | 34.80 Mn |
| Apr 3, 2022 | 14.44 Mn |
| Oct 3, 2021 | 4.36 Mn |
| Jul 4, 2021 | 7.20 Mn |
| Apr 4, 2021 | 5.16 Mn |
| Jan 3, 2021 | 7.13 Mn |